The current valuation score of Biogen Inc is 9.48, ranking 23 out of 154 in the Pharmaceuticals industry. Its current P/E ratio is 22.73, which is 46.79% below the recent high of 33.36 and 100.00% above the recent low of 0.00.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.